Research Summary

Top US Cancer Centers Often Diverge From USPSTF Cancer Screening Guidance, Cross-Sectional Study Finds

Edited by:
Ashton L. Stahl

Key Highlights

  • A cross-sectional study compared USPSTF cancer screening recommendations with those published by the top 10 US cancer centers for average-risk patients.
  • The analysis covered colorectal, lung, cervical, prostate, and breast cancer screening recommendations.
  • Variability was substantial for breast, prostate, and cervical cancer, while lung and colorectal cancer recommendations were generally concordant with USPSTF guidance.
  • Discordant recommendations were usually in the direction of more screening and often did not include discussion of potential risks and harms.

PUPC ad

In the study, published in eClinicalMedicine, researchers reported that recommendations from the top 10 US cancer centers were not consistently aligned with the US Preventive Services Task Force (USPSTF) for average-risk cancer screening. The authors said the greatest variability was seen for breast cancer, prostate cancer, and cervical cancer. In contrast, guidance for lung cancer and colorectal cancer was generally concordant between the cancer centers and the USPSTF.

The investigators framed the issue around the USPSTF’s role as an independent volunteer body that publishes evidence-based cancer screening guidelines, while noting that those recommendations are not binding and that individual cancer centers often publish their own screening advice.

The researchers conducted a cross-sectional study comparing screening recommendations from the top 10 US cancer centers, as ranked by US News & World Report 2022-2023, with USPSTF recommendations for average-risk patients. They evaluated recommendations for colorectal, lung, cervical, prostate, and breast cancers. Variables assessed included the recommended screening test, the direction of the recommendation, its strength, screening frequency, starting age, ending age, and whether risks and benefits were discussed or quantified.

Study Findings

The study found substantial variability between cancer center recommendations and USPSTF guidance for breast, prostate, and cervical cancer screening. According to the indexed article summary, discordance was almost always in the direction of cancer centers recommending more screening than the USPSTF. The authors also reported that these more intensive recommendations were commonly presented without discussion of potential risks and harms.

By contrast, recommendations for lung cancer and colorectal cancer were generally concordant with USPSTF guidance. The study summary available from the source did not provide numerical counts of discordant centers or test-specific breakdowns beyond the cancer-type-level findings, so the results should be interpreted within the level of detail reported in the source summary.

Clinical Implications

According to the study authors, the findings suggest that inconsistent messaging from highly visible US cancer centers could have population-level implications, including public confusion about appropriate cancer screening. They further stated that many centers omitted a nuanced discussion of benefits and risks despite recommending screening beyond USPSTF guidance.

This study had limitations. For example, this cross-sectional analysis reflects publicly available website content that could have changed since the investigators’ most recent review, and differences in update timing between cancer center websites and USPSTF guidance may have contributed to some discrepancies. The study also used USPSTF recommendations as the comparison standard rather than evaluating whether cancer center recommendations improved mortality, and its findings from the top 10 US cancer centers may not generalize to other institutions or reflect the practices of individual physicians.

Expert Commentary

“Top Ten US Cancer Centers make screening recommendations inconsistent with those of the USPSTF recommendations, with cancer centers generally recommending more screening and omitting a nuanced discussion of benefits and risks,” the researchers concluded.

Reference
Wright K, Shkabari B, Booth C, Knopf K, Tregear M, Gyawali B. Congruence of cancer screening recommendations between the USPSTF and the top ten US cancer centers: a cross sectional study. eClinicalMedicine. 2025;82:103169. doi:10.1016/j.eclinm.2025.103169